RecruitingNot Applicable

Minimally Invasive Hemodynamic Monitoring in Cardiac Ablation

Turkey (Türkiye)27 participantsStarted 2026-04-30

Plain-language summary

This prospective observational clinical study aims to evaluate the clinical utility of Pressure Recording Analytical Method (PRAM)-based minimally invasive hemodynamic monitoring in patients undergoing cardiac ablation procedures. The study will be conducted in the cardiac catheterization laboratory of Istanbul University-Cerrahpaşa Cardiology Institute and will include 27 adult patients scheduled for catheter ablation. Written informed consent will be obtained from all participants, and the study will adhere to the principles of the Declaration of Helsinki.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years * Patients scheduled for cardiac catheter ablation in the electrophysiology laboratory * Indication for ablation confirmed by a cardiologist * Ability to provide written informed consent * Planned invasive arterial blood pressure monitoring during the procedure Exclusion Criteria: * Refusal or inability to provide informed consent * Failure to identify arrhythmogenic focus leading to cancellation of ablation procedure * Severe hemodynamic instability prior to procedure * Contraindication to invasive arterial catheterization * Incomplete hemodynamic data acquisition * Pregnancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Cardiac Output measured by PRAM during catheter ablation

Timeframe: Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

Trial details

NCT IDNCT07603765

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11-15

Contact for this trial

GOZDE ALTUN

+905544290333 gozde.altun@iuc.edu.tr

View on ClinicalTrials.gov More Cardiac Arrythmias trials